In high-income countries like the United States, NASH-related cirrhosis was the second leading cause of liver transplantation among patients without HCC, and the leading cause in women without HCC [6]
During your consultation, your provider will tailor a plan matching your health needs, preferences, and insurance considerations
Natalie Hernandez , the program combines advanced pediatric endocrinology with evidence-based nutrition, movement coaching, behavioral support, hormone evaluation, and medicationsincluding GLP-1 therapieswhen medically appropriate
Fukunaka A, Fukada T, Bhin J, Suzuki L, Tsuzuki T, Takamine Y, et al
Your support means a lot to us
In 2025, the introduction of the oral Wegovy pill expanded options for those preferring non-injection treatments